"Is ketamine safe?" is one of the first questions almost every patient asks me before we talk about anything else — and it's the right question to lead with. Ketamine carries a reputation shaped by its history as a party drug, which makes people understandably cautious about using it as medicine. The reputation and the reality are two different things. Here's what the research actually shows, and what I look for before I'll approve anyone for treatment.
Ketamine's Actual Track Record
Ketamine isn't a new or experimental compound. It's an FDA-approved anesthetic that's been used safely in hospitals and surgical settings for more than 50 years — it's on the World Health Organization's List of Essential Medicines. What's newer is using it in much smaller, sub-anesthetic doses for treatment-resistant depression, anxiety, and PTSD. That use is well studied — the American Journal of Psychiatry has reported that roughly 70% of patients with treatment-resistant depression show significant improvement with ketamine therapy — but it's important to be precise: the anesthetic use is FDA-approved, and its use for depression and related conditions is what's called off-label, meaning providers are prescribing it based on a large and growing body of clinical evidence, not a formal FDA indication for that specific purpose. That's an accepted and common practice in medicine, but patients deserve to know the distinction rather than assume "FDA-approved" applies to everything about how it's being used.
Why It Works Differently Than What You've Tried Before
Most antidepressants target serotonin and take weeks to have any effect — and for roughly a third of patients, they don't work well enough at all. Ketamine works on a completely different system, the brain's glutamate pathway, which is one of its primary communication networks. It blocks NMDA receptors and stimulates AMPA pathways in a way that promotes neuroplasticity — essentially helping the brain rebuild connections that chronic stress, depression, and trauma have worn down. That's also why the timeline is so different: where standard antidepressants can take four to six weeks to show any benefit, ketamine's effects are often measurable within hours to days.
What A Responsible Screening Actually Looks Like
- A full review of your mental health history and current medications
- A real conversation about cardiovascular health — ketamine can raise blood pressure and heart rate
- Screening for a personal history of psychosis or substance misuse involving ketamine specifically
- An honest conversation if you're not a candidate — not everyone is, and I'll tell you if that's the case
- Sedation-trained staff on-site for every single session, which Utah law requires and which I take seriously regardless
What Happens During A Session
Sessions take place in a quiet, comfortable clinical space, not a hospital ward. You receive a sub-anesthetic dose that produces a temporary dissociative state — a sense of mental detachment that fully resolves before you leave — and sessions typically run 40 to 60 minutes. You'll need a driver, since you shouldn't operate a vehicle for the rest of that day. Our standard protocol is 8 treatments over the first four weeks, followed by 4 more over the next four weeks, for 12 total, with maintenance sessions afterward based on how you're responding. Some patients notice a difference after their first or second session; others take longer. I check in with every patient throughout, not just at the start.
Who I Don't Approve For Treatment
This is the part that matters most to me, and it's the part that gets glossed over by programs that are more interested in filling appointment slots than screening properly. I don't approve patients with uncontrolled high blood pressure or certain heart conditions, active psychosis, or a history of ketamine misuse specifically — the medical history has to be reviewed carefully, not rubber-stamped. As a board-certified nurse practitioner practicing under Utah's full practice authority law, I evaluate, prescribe, and manage every ketamine treatment plan on my own license — no physician co-signature required — and that responsibility is exactly why the screening comes first, every time, no exceptions.
"The medication itself has an excellent safety record when it's used the way it's supposed to be used — screened properly, dosed conservatively, and monitored the whole way through. What actually worries me is patients trying to shortcut that process somewhere else. If a program isn't asking about your cardiovascular history or your psychiatric history in real depth before your first session, that's a program skipping the part that keeps people safe."
The Bottom Line
Ketamine has a genuinely strong safety record — both as a 50-year-old anesthetic and as a well-studied off-label treatment for depression, anxiety, and PTSD that hasn't responded to standard care. The real variable isn't the medication itself; it's whether the person prescribing it is actually screening you, monitoring you, and being honest with you about whether you're a good fit. If you're considering ketamine therapy, ask whoever you're considering exactly what their screening process looks like before you ask about pricing or scheduling. That question tells you more than almost anything else.
Considering Ketamine Therapy?
We'll start with a real medical and psychiatric history, screen for candidacy honestly, and walk you through exactly what to expect before you commit to anything.
This article is for educational purposes only and does not constitute medical advice. Please consult a qualified provider before starting any new treatment. — Abbott Health & Wellness, 45 North State Street, Salina, UT 84654.